Consistently, Salvador-Martín et al. revealed [50] that GBP1 was downexpressed in responders compared with nonresponders in UC, and Lykowska-Szuber et al. reported [51] that IL1B was significantly downregulated in responders in Crohn's disease. This evidence concerns the gene GBP1 and Crohn disease.